Psyence Biomedical Cash Flow Statement (2023-2025) | PBM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2023	Sep2023	Sep2024	Sep2025
Operating Activities
Net Income (Quarter)	-3.23M	-0.31M	0.14M	-1.50M
Gains from Investment Securities (Quarter)			0.00M	-0.06M

Psyence Biomedical (PBM)

NASDAQ: PBM

$2.91 ▲ +0.09 (+3.19%)

Jul 24, 2026 · 3:59 PM UTC